Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
SSM Popul Health ; 16: 100948, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34754896

RESUMO

There might be an association between Internet addiction (IA) and loneliness; however, inconsistent evidence suggests that the severity of this association remains unclear. This study was conducted to assess the association between IA and loneliness. A systematic literature search was conducted in four online databases, including PubMed (MESH terms), Web of Science, Scopus, and Embase. Observational studies measuring the association between IA and loneliness were screened and included in this review. A meta-analysis was conducted using the Stata software. Twenty-six articles with a total sample size of 16496 subjects were included in the analysis. A moderate positive association (r = 0.15 (95% CI: 0.13, 0.16)) was found between IA and loneliness. The individuals with IA had significantly higher scores of loneliness. According to this meta-analysis, we need more attention to the early symptoms of loneliness in individuals with IA. Longitudinal studies are needed to determine the temporality of this association considering adjustment for time varying confounders.

2.
Diabetes Metab Syndr ; 15(2): 479-485, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33662834

RESUMO

BACKGROUND AND AIMS: To elucidate the effect modification of general and central obesity by sex and age on the risk of cardiovascular events. METHODS: The analysis included 14,983 males and females aged 45-75 years from the Atherosclerosis Risk in Communities study. Obesity was defined with body mass index (BMI), waist-to-hip ratio (WHR) and body shape index (BSI) which categorized the participants as obese and non-obese. Targeted maximum likelihood estimation was used to estimate the risk ratio (RR) with the tmle package in R software. RESULTS: After adjustment, the strongest effect of BMI on CHD was in females (RR (95%CI): 1.26 (1.11, 1.42)) and in age>54 (RR (95%CI): 1.16 (1.06, 1.27)) and for HF it was in age>54 (RR (95%CI): 1.18 (1.10, 1.26)) and in females (RR (95%CI): 1.17 (1.08, 1.28)). Regarding central obesity, WHR (RR (95%CI): 1.19 (1.05, 1.34)) had the strongest effects on CHD for males and BSI (RR (95%CI): 1.140 (1.02, 1.26)) for age ≤ 54, and for HF the WHR (RR (95%CI): 1.22 (1.10, 1.36)) and BSI (RR (95%CI): 1.18 (1.07, 1.30)) had the strongest effects for age≤54, respectively. CONCLUSION: Among males and age≤54, WHR index was associated with a higher risk of CHD and HF while BMI was so for females and age>54.


Assuntos
Aterosclerose/epidemiologia , Índice de Massa Corporal , Doenças Cardiovasculares/epidemiologia , Serviços de Saúde Comunitária/métodos , Obesidade Abdominal/epidemiologia , Fatores Etários , Idoso , Aterosclerose/sangue , Aterosclerose/diagnóstico , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/diagnóstico , Estudos de Coortes , Feminino , Seguimentos , Humanos , Funções Verossimilhança , Masculino , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/diagnóstico , Obesidade/epidemiologia , Obesidade Abdominal/sangue , Obesidade Abdominal/diagnóstico , Estudos Prospectivos , Fatores de Risco , Fatores Sexuais
3.
Cardiovasc Endocrinol Metab ; 10(1): 45-50, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33634255

RESUMO

BACKGROUND: Role of leptin is well documented in cardiometabolic diseases. The objective of this study was to investigate if the serum levels of leptin associates with the serum levels of markers related to cardiac and metabolic disorders in adults. MATERIALS AND METHODS: One hundred eighty subjects [120 cardiovascular disease (CVD) and 60 healthy controls] were enrolled in the study, to determine the association of the serum leptin (in quartiles) and cardiometabolic diseases [metabolic syndrome (MetS) and CVD] adjusted for other biological and physical examination. MetS was according to the WHO Clinical Criteria for MetS definition and CVD by angiography outcomes. The serum levels of leptin and OX-LDL were measured by ELISA. RESULTS: Leptin levels were significantly higher in patients with MetS and those with positive angiography compared with controls. After controlling for potential confounders, a significant association of the leptin levels with cardiometabolic diseases was proven, albeit there was a higher rate of significance between CVD and leptin in comparison with MetS. Additionally, receiver operating characteristic analysis revealed that the serum levels of leptin were a valuable biomarker of the cardiometabolic diseases. CONCLUSION: Our findings demonstrate that serum leptin levels are associated with components of the MetS and with CVD. Serum leptin may be a useful biomarker for CVD.

4.
Obes Sci Pract ; 6(6): 628-637, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33354341

RESUMO

OBJECTIVES: The association of body mass index (BMI) with the risk of cardiovascular disease among diabetic patients is controversial. This study compared the effects of BMI and central obesity on stroke in diabetics and non-diabetics using targeted maximum likelihood estimation. MATERIALS AND METHODS: This analysis included 12 725 adults aged 45-75 years, after excluding prevalence cases and participants with missing data, from the Atherosclerosis Risk in Communities study. Obesity was defined with BMI, waist circumference, waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), body shape index (BSI) and body roundness index (BRI), which categorized all participants as obese and non-obese. Generalized linear models and TMLE (with the tmle package) were used to estimate risk ratio (RR). RESULTS: During 27 years of follow-up, 1078 (8.47%) cases of stroke occurred. After adjustment for demographic, behavioural, biologic and central obesity variables, the effect of BMI decreased in both diabetics and non-diabetics. The effect of BMI in diabetics was more attenuated, in full model, (RR: 1.04 [0.90, 1.20]) rather than non-diabetics (RR: 1.11 [1.00, 1.24]). This attenuation was more related to biologic variables in non-diabetics and central obesity in diabetics. With respect to central obesity, BSI (RR [95% CI]: 1.15 [0.96, 1.38]) and WHR (RR [95% CI]: 1.15 [0.87, 1.52]) had strongest and marginally significant effects for diabetics and BSI (RR [95% CI]: 1.10 [1.02, 1.20]) for non-diabetics. CONCLUSIONS: Among diabetics, BSI and WHR indices were associated with a higher incidence of stroke. Future studies should consider how central obesity affects higher incidence of stroke among diabetics stratified by sex and age groups.

5.
Acta Parasitol ; 65(3): 569-584, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32319035

RESUMO

BACKGROUND: Toxocariasis is one of the neglected zoonosis with considerable public health importance around the world. The current study aimed to elucidate the overall prevalence of Toxocara infection in human and definitive hosts and also the contamination of soil and raw vegetables with the ova of these parasites, in Iran, using systematic review and meta-analysis. METHODS: Six English and Persian databases were explored from 2000 to 2017 using the terms toxocariasis, Toxocara spp., visceral larva migrans, Iran, epidemiology, and prevalence. This meta-analysis conducted using STATA, and for all statistical tests, a p value less than 0.05 was considered significant. The random-effects model was used to the report of the pooled prevalence with a 95% confidence interval (CI). RESULTS: The pooled prevalence of toxocariasis in human was calculated as 11% (95% CI 8-13%). In terms of definitive hosts, the pooled prevalence of Toxocara infection in dogs and cats were calculated as 17% (95% CI 14-20%) and 37% (95% CI 26-48%), respectively. Also, the pooled prevalence of Toxocara spp. eggs in the soil and raw vegetable samples were calculated as 18% (95% CI 13-23%) and 2% (95% CI 1-3%), respectively. CONCLUSIONS: The results of current study demonstrate that toxocariasis should be taken more seriously by health authorities. Implementing an appropriate control program is necessary to reduce the incidence of this disease in Iran.


Assuntos
Toxocaríase/epidemiologia , Zoonoses/epidemiologia , Animais , Doenças do Gato/epidemiologia , Doenças do Gato/parasitologia , Gatos , Doenças do Cão/epidemiologia , Doenças do Cão/parasitologia , Cães , Humanos , Incidência , Irã (Geográfico)/epidemiologia , Prevalência , Saúde Pública , Toxocara/parasitologia
6.
Arch Acad Emerg Med ; 8(1): e41, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32259130

RESUMO

There are significant misconceptions and many obstacles in the way of illuminating the epidemiological and clinical aspects of COVID-19 as a new emerging epidemic. In addition, usefulness of some evidence published in the context of the recent epidemic for decision making in clinic as well as public health is questionable. However, misinterpreting or ignoring strong evidence in clinical practice and public health probably results in less effective and somehow more harmful decisions for individuals as well as subgroups in general populations of countries in the initial stages of this epidemic. Accordingly, our narrative review appraised epidemiological and clinical aspects of the disease including genetic diversity of coronavirus genus, mode of transmission, incubation period, infectivity, pathogenicity, virulence, immunogenicity, diagnosis, surveillance, clinical case management and also successful measures for preventing its spread in some communities.

7.
J Gastrointest Cancer ; 51(2): 401-411, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31338727

RESUMO

PURPOSE: Colorectal cancer (CRC) is one of the most important cancers, which has various patterns in the world. The aim of this study was to determine the factor associated to survival and looking for screening in Iran. METHODS: A literature search was conducted using PubMed, Web of Science, Scopus, SID, and Magiran on June 30, 2018. Studies that performed survival analysis and the barrier of screening for colorectal cancer were included in this review. RESULTS: Fifty-three articles for survival and 11 for screening were included and examined. The important factors of survival are the age, cancer stage, tumor grade, ethnicity, marital status, family history of cancer, smoking, metastasis, and obesity. For barrier of screening, the cost, shame, fear of diagnosis the cancer, absence of clinical symptoms, and time limit were determined. CONCLUSION: Remarkably, knowledge, attitude, and behaviors about CRC screening in Iran are very moderate to poor. According to diversity of survival rates and low tendency to screening, we need to further and deepen studies of barrier and facilitators of screening.


Assuntos
Neoplasias Colorretais/diagnóstico , Adulto , Idoso , Neoplasias Colorretais/mortalidade , Detecção Precoce de Câncer , Feminino , Humanos , Irã (Geográfico) , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Análise de Sobrevida , Adulto Jovem
8.
Epidemiol Health ; 41: e2019049, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31801319

RESUMO

OBJECTIVES: This study was conducted to identify and characterize the barriers and motivations to physical activity (PA) for elderly adults in Iran and other countries. METHODS: We searched 6 databases (PubMed, Embase, Scopus, Web of Science, Magiran, and the Scientific Information Database) from 2000 to the November 2017, using "aged 60 and over," "physical activity" or "exercise," and "motivator" and "barrier" as keywords. Two reviewers independently performed the search, screening, and quality assessment of the studies. RESULTS: In total, 34 papers were finally included in the study. The most important barriers, based on the frequency of factors, included physical problems, having no companions, and physical barriers to walking. The motivators included improving one's physical condition, being social, and suitability of the physical environment. CONCLUSIONS: Important motivators and barriers to PA were more closely related to intrapersonal factors than to the interpersonal and environmental domains. The barriers and motivators to PA in the elderly were not markedly different between Iran and other countries. Therefore, a general strategy could be designed to improve PA in the elderly.


Assuntos
Exercício Físico , Idoso , Exercício Físico/psicologia , Humanos , Internacionalidade , Irã (Geográfico) , Motivação
9.
J Hum Hypertens ; 33(11): 775-785, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-31551569

RESUMO

To understand the genetic architecture and make inferences about transmissible resemblance of systolic and diastolic blood pressure (SBP and DBP) traits in relatives, the polygenic effect of individual alleles in terms of narrow heritability (h2) is usually assessed. The heritability estimates for BP traits are population specific parameters with a wide range in different studies (6-68%), and there is no comprehensive evidence comparing its source(s) of heterogeneity. To fill the gap, this systematic review and meta-analysis study was carried out. Using MeSH terms, 647 records were detected through searching, "Pubmed," "Ebsco," "Web of Science," and "Scopus" databases. From these, 24 relevant full-text articles with 47 comparisons for final quantitative meta-analysis were included in our review over the five continents. The additive genetic effects of both traits showed a widespread distribution (h2SBP: 17-52%, h2DBP:19-41%). Different categories of transmissible resemblance for BP traits were explained by ethnicity; higher heritability was estimated in Europeans and Mexican Americans, while lower heritability was seen in the Middle Eastern, Asians, Africans, Latinos, Hispanics, and American Indians. Low heterogeneity of polygenic effects was seen for both traits in subgroups of the Middle East, Asians, Africans, and Latinos, Hispanics, American Indians. However, there was a substantial heterogeneity of h2 within European and Mexican American studies. Neither pedigree type nor other covariates explained the variance of additive genetic effects of BP traits in different ethnicities.


Assuntos
Pressão Sanguínea/genética , Etnicidade/genética , Hereditariedade , Hipertensão/genética , Herança Multifatorial , Grupos Raciais/genética , Predisposição Genética para Doença , Humanos , Hipertensão/diagnóstico , Hipertensão/etnologia , Hipertensão/fisiopatologia , Linhagem , Fenótipo , Fatores de Risco
10.
Travel Med Infect Dis ; 17: 5-18, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28450185

RESUMO

BACKGROUND: With increased international travel over the world the need for safe and effective chemoprophylaxis for malaria is as great as ever. The choice of regimen is difficult, as effectiveness should be weighted against potential adverse effects. Although, some studies have reported high prophylactic efficacy of primaquine, there is no comprehensive evidence comparing its prophylactic effectiveness as well as toxicity. To fill the gap, this systematic review and meta-analysis study was carried out. METHODS: Using MeSH terms, 756 records were detected through searching "Pubmed", "Embase","Web of Science"and "Cochrane" databases. From these,7 relevant full-text articles with 14 comparisons for final quantitative meta-analysis were included in our review. In order to make a comparison between the studies, Risk Ratios(RRs) and their 95% confidence intervals(CIs) were estimated. RESULTS: Overall,74% reduction in the incidence of parasitaemia by primaquine versus other prophylactic regimens was estimated(RRoverall = 0.26, CI 95%:0.16-0.41--RRvivax = 0.16, CI 95%:0.07-0.36--RRfalciparum = 0.31, CI 95%:0.18-0.55). The incidence rate ratios for adverse effects showed no statistically significant difference between primaquine and control groups (p > 0.05). CONCLUSIONS: For persons without G6PD deficiency, who are not pregnant, primaquine is the most effective presently available prophylactic for P. vivax malaria and comparable to such regimens as doxycycline, mefloquine and atovaquone-proguanil for the prevention of P. falciparum malaria.


Assuntos
Antimaláricos/uso terapêutico , Malária Falciparum , Malária Vivax , Parasitemia , Primaquina/uso terapêutico , Antibioticoprofilaxia/métodos , Antibioticoprofilaxia/estatística & dados numéricos , Humanos , Malária Falciparum/tratamento farmacológico , Malária Falciparum/epidemiologia , Malária Falciparum/parasitologia , Malária Vivax/tratamento farmacológico , Malária Vivax/epidemiologia , Malária Vivax/parasitologia , Parasitemia/tratamento farmacológico , Parasitemia/epidemiologia , Parasitemia/parasitologia , Plasmodium falciparum , Plasmodium vivax , Viagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...